Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Substance Use and Media Preferences

2. listopadu 2026 aktualizováno: Ruschelle Leone, University of Colorado, Denver

The goal of this randomized clinical trial is to learn how alcohol use, cannabis use, and using both substances affect whether and how quickly people stop a video being shown to a woman. The study will recruit 312 people from the Metro-Denver area who drink alcohol and use cannabis; half of the participants will be women. The main questions it aims to answer are:

  • How do alcohol, cannabis, and their combined use affect whether participants stop the video and how quickly they do so?
  • Does alcohol use versus alcohol and cannabis use by others in the scenario affect whether and how quickly participants stop the video?

Researchers will compare four randomly assigned groups: alcohol only, cannabis only, both alcohol and cannabis, and neither substance. Participants will also be randomly assigned to one of two scenarios involving alcohol use or alcohol and cannabis use by others. These comparisons will help researchers understand how participants' own substance use and substance use by others affect their decisions to intervene.

Participants will:

  • Complete a phone call to review the study and schedule a mobile laboratory visit at their home.
  • Have their ID checked, complete a breath alcohol test to confirm no alcohol is in their system, and be weighed. Female participants will also take a pregnancy test.
  • Provide written consent and complete questionnaires so researchers can confirm eligibility before random assignment.
  • Follow their assigned substance-use condition. Participants in the cannabis-only group will smoke their usual cannabis at home while staff monitor them through Zoom. Those in the alcohol-only group will drink two weight-based alcoholic beverages, with a target blood alcohol concentration of 0.08%. Those assigned to both substances will use cannabis first and then drink alcohol. Those assigned to neither substance will not use either as part of the study.
  • Provide blood and breath samples to measure cannabis-related THC and alcohol levels.
  • Complete a task in which they can choose to stop a video being shown to a woman. Researchers will measure whether they stop the video and how long they take to do so.
  • Take part in a recorded interview about their experience and the reasons they did or did not stop the video. Researchers will analyze these interviews to better understand how substance use affects decisions.
  • Answer questions about what they believed the study was testing and their impressions of the other participants, receive an explanation of the study, and receive compensation.

Přehled studie

Typ studie

Intervenční

Zápis (Odhadovaný)

312

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

    • Colorado
      • Denver, Colorado, Spojené státy, 80045
        • University of Colorado Anschutz Medical Campus
        • Kontakt:
        • Vrchní vyšetřovatel:
          • Ruschelle Leone, PhD

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

21 let až 30 let (Dospělý)

Přijímá zdravé dobrovolníky

Ano

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  1. Provision of signed and dated informed consent form.
  2. Stated willingness to comply with all study procedures and lifestyle considerations .
  3. Aged 21-30, verified by a photo ID.
  4. Consume an alcohol quantity on a single occasion that is equal to or greater than the dose administered in the laboratory on ≥ 3 days in the past year (see Table 1).
  5. Smoked cannabis ≥ 3 days in the past year.
  6. Engaging in simultaneous alcohol and cannabis use ≥ 1 day in the past year.

Exclusion Criteria:

  1. Currently being treated or in recovery for alcohol or drug problems; currently interested in seeking treatment for drinking or drug use via self-report.
  2. Experienced an adverse event while co-using alcohol and cannabis at any time in the past 3 months.
  3. Any medical or psychiatric condition, as well as current use of a medication, that would contraindicate alcohol administration as determined by the Study Physician.
  4. Acute Psychiatric Symptomatology: elevated psychological distress as indicated by a score greater than 65 on the Brief Symptom Inventory.
  5. Self-report that a participant is trying to get pregnant, currently pregnant, or a positive pregnancy test.
  6. Combined height and weight that is either less than 6 feet tall and over 230 lbs, or over 250 lbs and over 6 ft tall as measured during the lab visit or by a valid photo ID.
  7. Current or past participation in PI Leone's research study 'Understanding the Influence of Alcohol and Media on Relationships' protocol #24-1867.

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Základní věda
  • Přidělení: Randomizované
  • Intervenční model: Faktorové přiřazení
  • Maskování: Žádné (otevřený štítek)

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: Alcohol Consumption + Alcohol Consumption of Others

Participants will be assigned to drink alcohol and the others in the study will also be assigned to drink alcohol.

Participants will consume a moderate alcohol dose condition (target BrAC .08%) with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) approved alcohol administration procedures.

Others in the study will be assigned to drink alcohol

Experimentální: Alcohol Consumption + Alcohol/Cannabis Consumption of Others

Participants will be assigned to drink alcohol and the others in the study will be assigned to drink alcohol and consume cannabis.

Participants will consume a moderate alcohol dose condition (target BrAC .08%) with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) approved alcohol administration procedures.

Others in the study will be assigned to drink alcohol and consume cannabis

Experimentální: Alcohol/Cannabis Consumption + Alcohol Consumption of Others

Participants will be assigned to drink alcohol and consume cannabis; and the others in the study will be assigned to drink alcohol.

Others in the study will be assigned to drink alcohol

Participants in this group will self-administer legal-market flower cannabis Participants will consume a moderate alcohol dose condition (target BrAC .08%) with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) approved alcohol administration procedures.

Experimentální: Alcohol/Cannabis Consumption + Alcohol/Cannabis Consumption of Others

Participants will be assigned to drink alcohol and consume cannabis; and the others in the study will be assigned to drink alcohol and consume cannabis.

Others in the study will be assigned to drink alcohol and consume cannabis

Participants in this group will self-administer legal-market flower cannabis Participants will consume a moderate alcohol dose condition (target BrAC .08%) with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) approved alcohol administration procedures.

Aktivní komparátor: Sober + Alcohol Consumption of Others

Participants will be assigned to drink a non-alcohol control beverage; and the others in the study will be assigned to drink alcohol.

Others in the study will be assigned to drink alcohol

Participants will be assigned to a no-alcohol control beverage and to not consume cannabis.

Aktivní komparátor: Sober + Alcohol/Cannabis Consumption of Others

Participants will be assigned to drink a non-alcohol control beverage; and the others in the study will be assigned to drink alcohol and consume cannabis.

Others in the study will be assigned to drink alcohol and consume cannabis

Participants will be assigned to a no-alcohol control beverage and to not consume cannabis.

Experimentální: Cannabis Consumption + Alcohol Consumption of Others

Participants will be assigned to consume cannabis, and the others in the study will be assigned to drink alcohol.

Others in the study will be assigned to drink alcohol

Participants in this group will self-administer legal-market flower cannabis

Experimentální: Cannabis Consumption + Alcohol/Cannabis Consumption of Others

Participants will be assigned to consume cannabis, and the others in the study will be assigned to drink alcohol and consume cannabis.

Others in the study will be assigned to drink alcohol and consume cannabis

Participants in this group will self-administer legal-market flower cannabis

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Intervention Likelihood
Časové okno: Up to three hours after consent

Stopping a woman from watching content during the Bystander Intervention Paradigm (Parrott et al., 2012, Leone et al., 2015). Possible scores are 0 (not stopping) to 1 (stopping).

Up to three hours after consent
Intervention Speed
Časové okno: Up to three hours after consent

The amount of time the woman watches the sexually explicit film during the Bystander Intervention Paradigm (Parrott et al., 2012, Leone et al., 2015). Scores range from 0 to 4 minutes.

Up to three hours after consent
Number of Bystander Barriers
Časové okno: Up to four hours after consent

Count number of barriers experienced during the paradigm via a semi-structured interview.

Up to four hours after consent
Number of Bystander Facilitators
Časové okno: Up to four hours after consent

Count number of facilitators experienced during the paradigm via a semi-structured interview.

Up to four hours after consent

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

1. května 2027

Primární dokončení (Odhadovaný)

1. března 2031

Dokončení studie (Odhadovaný)

1. března 2031

Termíny zápisu do studia

První předloženo

2. listopadu 2026

První předloženo, které splnilo kritéria kontroly kvality

2. listopadu 2026

První zveřejněno (Aktuální)

6. listopadu 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

6. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

2. listopadu 2026

Naposledy ověřeno

1. listopadu 2026

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • 26-1956
  • R01AA032801 (Grant/smlouva NIH USA)

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

ANO

Popis plánu IPD

IPD will be available in the NIAAA Data Archive.

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit